Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyaDent BG vs Emdogain for Intrabony Defects
NCT07230522Completed
- Sponsor
- Medical University of Sofia
- Start
- Mar 2024
- Primary completion
- Jul 2024
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised trial of cross-linked hyaluronic acid in periodontitis (2 arms), sponsored by Medical University of Sofia. Primary endpoints: periodontal pocket depth reduction at 6 months, Clinical attachment gain at 6 months and 1 more. Started Mar 2024; status: completed.
02
Drugs
cross-linked hyaluronic acid
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07230522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07230522.